Tag(s):
Johnson & Johnson targets Synthes in record deal
Premium Article - Thursday, 28 April 2011
US healthcare powerhouse Johnson & Johnson has announced a US$21 billion acquisition of Swiss medical device maker Synthes, subject to antitrust approval.
Search GCR
Register for Free GCR Daily News
GCR April/May 2012
In this issue:
Survey: Australia • Howrey: in their words • Rod Sims interview • GCR cartel roundtable • GCR Live Law Leaders Asia-Pacific
GCR Live Events
Jun
20
GCR Live Financial Services and Competition Law 2012
Organiser: Global Competition Review
Wed, 20th June
London, United Kingdom
Jun
28
GCR Live Consumer Goods and Retail - Latin America 2012
Organiser: Global Competition Review
Thu, 28th June
São Paulo, Brasil
Oct
09
Nov
13
GCR Live 4th Annual Competition Law Review
Organiser: Global Competition Review
Tue, 13th November - Wed, 14th November
Brussels, Belgium
Feb
08
